实用医学杂志 ›› 2020, Vol. 36 ›› Issue (24): 3373-3377.doi: 10.3969/j.issn.1006⁃5725.2020.24.014

• 临床研究 • 上一篇    下一篇

胆道双塑料支架联合熊去氧胆酸对困难胆总管巨大结石的临床疗效

孙燕 ,李俊, 宋森涛 ,袁琼英, 傅晓 ,张晓东, 汪静, 关亚萍, 朱峰   

  1. 同济大学附属东方医院消化内科(上海200080)
  • 出版日期:2020-12-25 发布日期:2021-01-19
  • 通讯作者: 朱峰 E⁃mail:zfyzj@hotmail.com
  • 基金资助:
    上海市浦东新区卫生和计划生育委员会学科特色专病建设项目(编号:PWZzb2017⁃02)

Clinical effect of double plastic biliary stents implantation combined with ursodeoxycholic acid in the treat⁃ment of difficultly large stone in common bile duct

SUN Yan,LI Jun,SONG Sentao,YUAN Qiongying,FU Xiao,ZHANG Xiaodong,WANG Jing,GUAN Yaping,ZHU Feng
  

  1. Department of Gastronenterology,Dongfang Hospital Affiliated to Tongji University,Shanghai 200080,China

  • Online:2020-12-25 Published:2021-01-19
  • Contact: ZHU Feng E⁃mail:zfyzj@hotmail.com

摘要:

目的 回顾性分析胆道双塑料支架置入联合熊去氧胆酸(UDCA)对困难胆总管巨大结石 ≥15 mm)的临床疗效。方法 收集我院2018年1月至2019年12月困难胆总管巨大结石患者63例,均通过 内镜下逆行胰胆管造影(ERCP)放置胆道双塑料支架,其中32例患者术后联合UDCA 15 mg/(kg·d)口服(观察 组),疗程3个月;31例患者未予口服药物(对照组)。3个月后拔除支架并行取石术,比较两组间第二次ERCP 术前腹痛腹胀、肝功能异常、胆管炎、支架梗阻发生率、最大结石直径变化及取石成功率的差异。结果 所有 患者ERCP 均取得成功,两次ERCP 均未发生消化道出血、穿孔、重症急性胰腺炎等重大并发症。观察组第 二次ERCP术前腹痛腹胀、肝功能异常、胆管炎及术中支架梗阻发生率分别为6.3%(2/32)、18.8%(6/32)、3.1% (1/32)、15.6%(5/32),均明显低于对照组25.8%(8/31)、45.2%(14/31)、22.6%(7/31)、38.7%(12/31),差异均有 统计学意义(χ2 = 4.510、5.069、5.376、4.259,P = 0.043、0.024、0.026、0.039)。观察组两次 ERCP 最大胆总管 结石直径中位数分别为 17、12 mm;对照组分别为 17、15 mm,均较首次 ERCP 有明显缩小,差异均有统计学 意义(Z = 4.659、4.736,均 P < 0.01)。观察组最大胆总管结石直径降低均值较对照组更为显著(Z = 3.883 P < 0.001);二次ERCP取石成功率观察组为90.6%(29/32)、明显高于对照组71.0%(22/31),差异有统计学意义 χ2 = 3.946,P = 0.047)。结论 困难胆总管巨大结石患者放置胆道双塑料支架配合UDCA可更有效降低再次 ERCP术前腹痛腹胀、肝功能异常、胆管炎及支架梗阻的发生率,降低最大结石直径,提高取石成功率。

关键词:

Abstract:

Objective This study tried to analyze the clinical effect of double plastic biliary stent implan⁃ tation combined with ursodeoxycholic acid(UDCA)in the treatment of difficult large stone(≥ 15 mm)in common bile duct(CBD). Methods Sixty⁃three patients with difficult CBD large stone from January 2018 to December 2019 in our hospital were enrolled,All the patients were placed double plastic biliary stents by endoscopic retrograde cholangiopancreatography(ERCP). Thirty ⁃two patients in the observation group received oral administration of UDCA 15 mg/(kg · d)for 3 months after ERCP while the other 31 patients without UDCA were included in the control group. Stents in each patient were pulled out 3 months after the first ERCP. The incidence of abdominal pain or distention,abnormal liver function,cholangitis before second ERCP and stents obstruction,diameter change of the largest CBD stone and success rate of stone removal during second ERCP were compared between the two groups. Results ERCP was successful in all patients and no serious complications(such as gastrointestinal bleeding,perforation,and severe acute pancreatitis)occurred during two operations. The incidence of abdominal pain or distension,liver dysfunction,cholangitis before second ERCP and stents obstruction found in second ERCP in the observation group was 6.3%(2/32),18.8%(6/32),3.1%(1/32)and 15.6%(5/32)respectively which was significantly lower than the according index of 25.8%(8/31),45.2%(14/31),22.6%(7/31)and 38.7% (12/31)in the control group. The difference between the two groups was statistically significant (χ2 = 4.510 5.069,5.376,4.259;P = 0.043,0.024,0.026,0.039). In the observation group,the median value of the diameter of the largest CBD stone was 17 mm and 12 mm respectively during two ERCP operations,while in the control group was 17 mm and 15 mm. The diameter of the largest CBD stone in both groups were significantly reduced in the second ERCP compared with first ERCP and the differences were statistically significant(Z = 4.659,4.736;P < 0.001). The effect of the mean stone diameter reduction was more significant in the observation group(Z = 3.883,P < 0.001). The success rate of stone removal in second ERCP was 90.6%(29/32)in the observation group and 71.0% (22/31)in the control group with statistically significant difference(χ2 = 3.946,P = 0.047). Conclusions In patients with difficultly large CBD stone,double biliary plastic stents combined with UDCA could more effectively reduce the incidence of abdominal pain or distention,abnormal liver function,cholangitis and stents obstruction before secondary ERCP. It also could reduce the diameter of the largest CBD stone and thus improve the success rate of stone extraction.

Key words: